Skip to main content
. 2018 Jul 25;17:1533033818788529. doi: 10.1177/1533033818788529

Table 2.

The Outcome of Patients.

Status Percentage
Overall complete ablation 26/26 (100%)
Local recurrence at ablated site 2/26 (7.69%)
New intrahepatic recurrence 7/26 (26.9%)
Death 1/26 (3.85%)
1-year tumor-free survival 17/26 (67.4%)
2-year tumor-free survival 12/26 (46.1)
3-year tumor-free survival 9/26 (39.3%)